Dobutamine tri-isobutyric acid ester and the use thereof as a ca

Details Dobutamine tri-isobutyric acid ester and the use thereof as a ca Dobutamine tri-isobutyric acid ester and the use thereof as a ca

1985-08-23

1987-05-05

Trousof, Natalie

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

560138, A61K 3122, C07C10100

Patent

active

046633510

ABSTRACT:
A novel, orally administrable pro-drug form of dobutamine of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof.

REFERENCES:
patent: 2276619 (1942-03-01), Kulz
patent: 3987200 (1976-10-01), Tuttle et al.
patent: 4340603 (1982-07-01), Bodor et al.
patent: 4562206 (1985-12-01), Tuttle

Affiliated with

Also associated with

Rating

Dobutamine tri-isobutyric acid ester and the use thereof as a ca does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dobutamine tri-isobutyric acid ester and the use thereof as a ca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dobutamine tri-isobutyric acid ester and the use thereof as a ca will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2399579